Brief Report: Rare X Chromosome Abnormalities in Systemic Lupus Erythematosus and Sjögren's Syndrome
Rohan Sharma(Ashoka Trust for Research in Ecology and the Environment), R. Hal Scofield(Oklahoma Medical Research Foundation), Kristi A. Koelsch(Oklahoma Medical Research Foundation), Pamela Hughes, Andrew Huang(Washington University in St. Louis), Jennifer A. Kelly(Oklahoma Medical Research Foundation), Gideon M. Hirschfield(University Health Network), Michael H. Weisman(Stanford University), Wan‐Fai Ng(University College Cork), Kaustubh S. Chaudhari, Kathy L. Sivils(Oklahoma Medical Research Foundation), Anum Fayaaz, Lida Radfar(New York University), Ilias Alevizos(Amgen (United States)), Vivian P. Bykerk(Hospital for Special Surgery), Gunnel Nordmark(Uppsala University), Corinne Miceli‐Richard(Délégation Paris 5), Juan‐Manuel Anaya(University of the Coast), Xavier Mariette(Inserm), Astrid Rasmussen(Statens Serum Institut), Marta E. Alarcón‐Riquelme(Karolinska Institutet), Biji T. Kurien(Oklahoma Medical Research Foundation), Marie Wahren‐Herlenius(Karolinska Institutet), David M. Lewis(University of Leeds), Bernardo A. Pons‐Estel(Hospital Provincial de Rosario), Michael T. Brennan, Swamy Venuturupalli(Cedars-Sinai Medical Center), Roland Jonsson(University of Bergen), Daniel J. Wallace(Cedars-Sinai Medical Center), Christopher J. Lessard(Oklahoma Medical Research Foundation), Edward Keystone(University of Toronto), J.W. Cavett(Oklahoma Medical Research Foundation), Maureen Rischmueller(The University of Adelaide), Valerie M. Harris(Oklahoma Medical Research Foundation), Ke Liu(Yangzhou University), Shibo Li(University of Oklahoma Health Sciences Center), Per Eriksson(Linköping University), Torsten Witte(Medizinische Hochschule Hannover), Jacques‐Eric Gottenberg(Centre National de la Recherche Scientifique), Xianglan Lu(OU Health), Deborah S. Cunninghame‐Graham(King's College London), Barbara Segal(Hennepin County Medical Center), C. Erick Kaufman(University of Oklahoma Health Sciences Center), John B. Harley(Veterans Health Administration), Nelson L. Rhodus(University of Minnesota), Donald U. Stone, Sara Magnusson Bucher(Örebro University), Roald Omdal(Stavanger University Hospital), Michael D. Rohrer(University of Minnesota)
Cited by 49
Related Papers
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
|Annals of the Rheumatic Diseases|2020|2.8k
A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis
|New England Journal of Medicine|2000|1.8k
Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry
|Nature Immunology|2019|1.4k
Mycophenolate Mofetil or Intravenous Cyclophosphamide for Lupus Nephritis
|New England Journal of Medicine|2005|1.1k